Alitretinoin Completed Phase 2 Trials for Kaposi’s sarcoma / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002188A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma